Phathom Pharmaceuticals Inc.
PHAT | NASDAQ
$7.71
+$0.26 (+3.49%)
Sep 22, 2026, 1:35 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -17.58M | -30.37M | -21.15M | -29.97M | -75.81M | -94.32M | -74.45M | -85.58M | -91.45M | -82.85M | -79.57M | -43.24M | -40.97M | -37.81M | -55.05M | -51.09M | -50.92M | -40.67M | -35.83M | -36.66M | -36.55M | -34.84M |
Depreciation & Amortization | 114K | 110K | 128K | 156K | 172K | 177K | 193K | 191K | 197K | 214K | 185K | 121K | 123K | 146K | 168K | 175K | 149K | 128K | 135K | 130K | 131K | 125K |
Stock-Based Compensation | 6.71M | 5.53M | 5.61M | 9.3M | 8.27M | 5.54M | 6.69M | 5.64M | 6.1M | 5.63M | n/a | 6.14M | 7.25M | 7.05M | 6.66M | 5.82M | 5.89M | 5.78M | 4.34M | 4.42M | 4.24M | 3.82M |
Other Working Capital | -6.6M | 6.6M | -3.19M | 1.47M | -1.59M | 7.94M | -5.66M | 660K | -2.59M | 653K | -260K | -6.89M | 1.58M | -5.04M | -3.71M | 796K | 5.89M | -5.88M | -11.38M | -2.89M | 6.65M | -10.07M |
Other Non-Cash Items | 10.37M | 7.53M | 6.36M | 7.96M | 10.59M | 12.58M | 13.15M | 14.79M | 15.06M | 15.01M | 34.91M | 7.48M | 6.96M | 7.29M | 7.32M | 7.39M | 4.34M | 1.96M | 1.47M | 2.7M | 517K | 721K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.55M | 1.55M | 4.05M | -1.56M | -5.95M | -8.91M | -9.04M | 1.39M | -626K | -7.02M | 676K | -2.41M | 4.43M | -16.34M | 208K | 2.69M | 14.83M | -11.95M | -11.54M | 345K | 3.3M | -19.59M |
Operating Cash Flow | -1.93M | -15.65M | -5M | -14.12M | -62.73M | -84.93M | -63.46M | -63.57M | -70.72M | -69.02M | -43.8M | -31.91M | -22.2M | -39.67M | -40.7M | -35.02M | -25.72M | -44.76M | -41.42M | -29.07M | -28.36M | -49.77M |
Capital Expenditures | 61K | -61K | 115K | -27K | -97K | -18K | -5K | 86K | -46K | -40K | -475K | -939K | -6K | -214K | -412K | -134K | -428K | -67K | -100K | -14K | -45K | -169K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -105K | n/a | -229K | n/a | n/a | n/a | n/a | -130K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -44K | -61K | -87K | -27K | -97K | -18K | -5K | -44K | -46K | -40K | -475K | -939K | -6K | -214K | -412K | -134K | -428K | -67K | -100K | -14K | -45K | -169K |
Debt Repayment | n/a | -55.8M | n/a | n/a | n/a | n/a | 24.75M | n/a | 24.75M | 9.9M | 211.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 42.76M | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.55M | -128K | 276K | -564K | n/a | n/a | 1.3M | 282K | n/a | n/a | n/a | 13K | 111K | n/a | n/a | n/a | 95.45M | n/a | 163K | n/a | 104K | 412K |
Financial Cash Flow | 3.55M | 66.64M | -97K | -271K | 80K | n/a | 26.05M | 122.06M | 24.77M | 9.9M | 211.99M | 13K | 141.5M | 14.07M | n/a | 24.6M | 95.45M | n/a | 163K | 44.03M | 104K | 412K |
Net Cash Flow | 1.58M | 50.93M | -5.19M | -14.41M | -62.75M | -84.95M | -37.42M | 58.44M | -45.99M | -59.16M | 167.72M | -32.84M | 119.3M | -25.81M | -40.95M | -10.55M | 69.3M | -44.82M | -41.36M | 14.95M | -28.31M | -49.52M |
Free Cash Flow | -1.87M | -15.65M | -4.89M | -14.14M | -62.73M | -84.95M | -63.46M | -63.49M | -70.77M | -69.06M | -44.27M | -32.85M | -22.21M | -39.88M | -41.11M | -35.15M | -26.14M | -44.82M | -41.52M | -29.08M | -28.41M | -49.93M |
Adj. Free Cash Flow | -8.58M | -21.18M | -10.5M | -23.44M | -71M | -90.49M | -70.15M | -69.12M | -76.87M | -74.69M | -44.27M | -38.99M | -29.46M | -46.93M | -47.77M | -40.97M | -32.03M | -50.6M | -45.86M | -33.5M | -32.65M | -53.75M |
Maintenance CapEx | -61K | -61K | 230K | n/a | n/a | n/a | n/a | 172K | n/a | n/a | n/a | -939K | -6K | -214K | -168K | -134K | -149K | -67K | -100K | -14K | -45K | -125K |
Growth CapEx | 122K | n/a | -115K | -27K | -97K | -18K | -5K | -86K | -46K | -40K | -475K | n/a | n/a | n/a | -244K | n/a | -279K | n/a | n/a | n/a | n/a | -44K |
Owner Earnings | -1.99M | -15.71M | -4.77M | -14.12M | -62.73M | -84.93M | -63.46M | -63.4M | -70.72M | -69.02M | -43.8M | -32.85M | -22.21M | -39.88M | -40.86M | -35.15M | -25.87M | -44.82M | -41.52M | -29.08M | -28.41M | -49.89M |
Add to Watchlist
Select watchlists to add or remove PHAT